Skip to Main Content

Advertisement intended for health care professionals

Umbrella Alt Text
Cart
header search
Search
Skip Nav Destination

Issue Archive

Volume 1, Issue 17
July 25 2017
Issue Cover

Table of Contents

EXCEPTIONAL CASE REPORTS

High-grade neutropenia in a patient successfully treated with nivolumab for refractory primary mediastinal B-cell lymphoma
Clinical Trials & Observations
Zachary Wright,Alexander Brown
View Articletitled, High-grade neutropenia in a patient successfully treated with nivolumab for refractory primary mediastinal B-cell lymphoma
Sequential bypassing agents during major orthopedic surgery: a new approach to hemostasis
Clinical Trials & Observations
Craig D. Seaman,Margaret V. Ragni
View Articletitled, Sequential bypassing agents during major orthopedic surgery: a new approach to hemostasis

CLINICAL TRIALS AND OBSERVATIONS

Treated secondary acute myeloid leukemia: a distinct high-risk subset of AML with adverse prognosis
Clinical Trials & Observations
Prajwal Boddu,Hagop M. Kantarjian,Guillermo Garcia-Manero,Farhad Ravandi,Srdan Verstovsek,Elias Jabbour,Gautam Borthakur,Marina Konopleva,Kapil N. Bhalla,Naval Daver,Courtney D. DiNardo,Christopher B. Benton,Koichi Takahashi,Zeev Estrov,Sherry R. Pierce,Michael Andreeff,Jorge E. Cortes,Tapan M. Kadia
View Articletitled, Treated secondary acute myeloid leukemia: a distinct high-risk subset of AML with adverse prognosis
Supplemental data

LYMPHOID NEOPLASIA

Th17 immune microenvironment in Epstein-Barr virus–negative Hodgkin lymphoma: implications for immunotherapy
Clinical Trials & Observations
Amy S. Duffield,Maria Libera Ascierto,Robert A. Anders,Janis M. Taube,Alan K. Meeker,Shuming Chen,Tracee L. McMiller,Neil A. Phillips,Haiying Xu,Aleksandra Ogurtsova,Alan E. Berger,Drew M. Pardoll,Suzanne L. Topalian,Richard F. Ambinder
View Articletitled, Th17 immune microenvironment in Epstein-Barr virus–negative Hodgkin lymphoma: implications for immunotherapy
Supplemental data

RED CELLS, IRON, AND ERYTHROPOIESIS

Red blood cells in hemorrhagic shock: a critical role for glutaminolysis in fueling alanine transamination in rats
Julie A. Reisz,Anne L. Slaughter,Rachel Culp-Hill,Ernest E. Moore,Christopher C. Silliman,Miguel Fragoso,Erik D. Peltz,Kirk C. Hansen,Anirban Banerjee,Angelo D’Alessandro
View Articletitled, Red blood cells in hemorrhagic shock: a critical role for glutaminolysis in fueling alanine transamination in rats
Supplemental data
Intestinal hephaestin potentiates iron absorption in weanling, adult, and pregnant mice under physiological conditions
Caglar Doguer,Jung-Heun Ha,Sukru Gulec,Chris D. Vulpe,Gregory J. Anderson,James F. Collins
View Articletitled, Intestinal hephaestin potentiates iron absorption in weanling, adult, and pregnant mice under physiological conditions

TRANSPLANTATION

HLA-mismatched unrelated donor transplantation using TLI-ATG conditioning has a low risk of GVHD and potent antitumor activity
Clinical Trials & Observations
Michael A. Spinner,Marcelo Fernández-Viña,Lisa E. Creary,Olivia Quinn,Linda Elder,Sally Arai,Laura J. Johnston,Everett H. Meyer,David B. Miklos,Lori S. Muffly,Robert S. Negrin,Judith A. Shizuru,Wen-Kai Weng,Ginna G. Laport,Samuel Strober,Robert Lowsky,Andrew R. Rezvani
View Articletitled, HLA-mismatched unrelated donor transplantation using TLI-ATG conditioning has a low risk of GVHD and potent antitumor activity
Supplemental data
  • Cover Image

    Cover Image

    issue cover

    COVER FIGURE
    The immunosuppressive ligand PD-L1 is abundantly expressed by Hodgkin/Reed-Sternberg cells and infiltrating immune cells in classic Hodgkin lymphoma. Brown staining with immunohistochemistry identifies the PD-L1 protein. See the article by Duffield et al.

  • PDF Icon PDF LinkFront Matter
  • PDF Icon PDF LinkEditorial Board
All Issues

Advertisement intended for health care professionals

Liver-related aspects of valoctocogene roxaparvovec gene therapy for hemophilia A: expert guidance for clinical practice
Imus PH, Pasca S, Tsai H-L, et al. Recipient clonal hematopoiesis in allogeneic bone marrow transplantation for lymphoid malignancies. Blood Adv. 2024;8(14):3849-3858.
A multicenter phase 2 clinical trial of low-dose subcutaneous decitabine in myelofibrosis
In vivo silencing of intestinal DMT1 mitigates iron loading in β-thalassemia intermedia (Hbbth3/+) mice
Antithrombotic efficacy and bleeding risks of vaccine-induced immune thrombotic thrombocytopenia treatments

Advertisement intended for health care professionals

Advertisement intended for health care professionals

  • American Society of Hematology
  • 2021 L Street NW, Suite 900
  • Washington, DC 20036
  • TEL +1 202-776-0544
  • FAX +1 202-776-0545

ASH Publications

American Society of Hematology

Copyright 2024 by American Society of Hematology
 
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal

Advertisement intended for health care professionals